News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski
May 4, 2025, 10:01

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CD56 expression modulates NAD+ metabolic landscape and may help predict sensitivity to anti-CD38 therapies and Isa-based regimens may provide comparable or even greater benefits than Dara-based regimens.”

Title: CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma

Authors: Giulia Giorgetti, Elena Maroto-Martin, Debora Soncini, Daniela Fenoglio, Pamela Becherini, Andrea Benzi, Silvia Ravera, Isabella Traverso, Francesco Ladisa, Francesco Lai, Giulia Rivoli, Dario Truffelli, Aimable Nahimana, Antonia Cagnetta, Fabio Guolo, Chiara R. M. Uras, Anaïs Schavgoulidze, Jessica Fong Ng, Alessio Nencioni, Santina Bruzzone, Nikhil C. Munshi, Roberto Massimo Lemoli, Mariateresa Fulciniti and Michele Cea.

Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski

You can read the Full Article on Blood Cancer Journal.

More posts featuring Robert Orlowski.

Aimable Nahimana Alessio Nencioni Anaïs Schavgoulidze Andrea Benzi Antonia Cagnetta cancer Chiara R. M. Uras Daniela Fenoglio Dario Truffelli Debora Soncini Elena Maroto-Martin Fabio Guolo Francesco Ladisa Francesco Lai Giulia Giorgetti Giulia Rivoli Isabella Traverso Jessica Fong Ng Mariateresa Fulciniti Michele Cea multiple myeloma Myeloma Paper of the Day Nikhil C. Munshi OncoDaily Oncology Pamela Becherini Robert Orlowski Roberto Massimo Lemoli Santina Bruzzone Silvia Ravera
Special Coverage
Opinion
May 21, 2025, 09:58
Charles Jiang Shared Top Tips for First-Time Trainees at ASCO25
Blog
May 21, 2025, 09:36
Carmen Monge-Montero: Join Webinar on Migration, Displacement and Cancer Care Access in Europe
Blog
May 21, 2025, 09:04
Sebastian Szmit: Pleasure to Present My Expertise for the Cardio-Oncology Conference at Yale New Haven Hospital
Blog
May 21, 2025, 08:51
Margaret Fitch Will Be Keynote Speaker at ONS- Nigeria Upcoming Conference
Science
May 21, 2025, 08:27
Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis
Science
May 21, 2025, 08:22
Vivek Subbiah: Cancer Treatment Paradigms in The Precision Medicine Era
Blog
May 21, 2025, 08:19
GAMPER Webinar June 2025: Radiobiological Aspects of Radiotherapy and the Potential for Hypofractionation
Blog
May 21, 2025, 08:19
Cathy Eng: Two of my earlyonset Colorectal Cancer patients were honored at this annual run in Owensboro
Blog
May 21, 2025, 08:07
Amy Comander: Honored to Volunteer at Roxbury Community Health Fair
Blog
May 21, 2025, 08:02
Catherine Alix-Panabières: Honored to Highlight Our Research on Liquid Biopsy at the CHU de Montpellier
Blog
May 21, 2025, 07:53
Helena Linardou: Last Chance to Vote for the IASLC Board Election by May 22
Blog
May 21, 2025, 07:32
Ruben Mesa: Grateful to Take On a New Role as Clinical Leader for Advocate Health’s National Cancer Program